- Home
- DXR vs BOWN Comparison
DXR vs BOWN Comparison
Compare DXR & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- BOWN
- Stock Information
- Founded
- DXR 1970
- BOWN 2023
- Country
- DXR United States
- BOWN United States
- Employees
- DXR N/A
- BOWN N/A
- Industry
- DXR Medical/Dental Instruments
- BOWN
- Sector
- DXR Health Care
- BOWN
- Exchange
- DXR Nasdaq
- BOWN Nasdaq
- Market Cap
- DXR 37.6M
- BOWN 32.1M
- IPO Year
- DXR N/A
- BOWN 2023
- Fundamental
- Price
- DXR $7.24
- BOWN $3.78
- Analyst Decision
- DXR Strong Buy
- BOWN
- Analyst Count
- DXR 1
- BOWN 0
- Target Price
- DXR $24.75
- BOWN N/A
- AVG Volume (30 Days)
- DXR 5.7K
- BOWN 26.9K
- Earning Date
- DXR 01-01-0001
- BOWN 01-01-0001
- Dividend Yield
- DXR N/A
- BOWN N/A
- EPS Growth
- DXR N/A
- BOWN N/A
- EPS
- DXR 0.35
- BOWN 0.39
- Revenue
- DXR $154,205.00
- BOWN N/A
- Revenue This Year
- DXR N/A
- BOWN N/A
- Revenue Next Year
- DXR N/A
- BOWN N/A
- P/E Ratio
- DXR $20.78
- BOWN $9.75
- Revenue Growth
- DXR N/A
- BOWN N/A
- 52 Week Low
- DXR $6.55
- BOWN $2.71
- 52 Week High
- DXR $10.00
- BOWN $11.00
- Technical
- Relative Strength Index (RSI)
- DXR 37.76
- BOWN 32.56
- Support Level
- DXR $7.00
- BOWN $2.71
- Resistance Level
- DXR $7.49
- BOWN $4.64
- Average True Range (ATR)
- DXR 0.33
- BOWN 1.10
- MACD
- DXR -0.01
- BOWN 0.11
- Stochastic Oscillator
- DXR 44.44
- BOWN 24.94
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.